Literature DB >> 8933874

Embolization with cellulose porous beads, I: An experimental study.

J Hamada1, Y Ushio, K Kazekawa, T Tsukahara, N Hashimoto, H Iwata.   

Abstract

PURPOSE: To study the possibility of using cellulose porous beads (CPBs) as a solid embolic material for the permanent occlusion of blood vessels.
METHODS: Unilateral renal arteries of 12 adult mongrel dogs were embolized with CPBs. Selective renal angiograms were obtained immediately, 1 hour, 4 weeks, and 12 weeks after the embolization. The dogs were killed 1 hour (n = 4), 4 weeks (n = 4), or 12 weeks (n = 4) after the procedure. The kidneys were removed en bloc and examined histologically.
RESULTS: The CPBs were easily injected through a microcatheter, were readily controlled with radiodensity, and did not adhere to the catheter. Renal angiograms obtained after embolization disclosed complete occlusion of the renal artery. Microscopically, the CPBs traveled to vessels with approximately the same diameter size. Larger vessels were occluded by aggregations of particles that left no open spaces. We found no disruption of the vessel wall, no evidence of perivascular hemorrhage, and no inflammatory changes of the vessel wall or the surrounding tissues.
CONCLUSION: The CPBs were easy to use; they reached distal sites and produced a homogeneous and permanent occlusion without specific inflammatory changes. The good results of this experimental study led to a clinical trial of CPBs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8933874      PMCID: PMC8337533     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  The utility of the microcrystalline cellulose sphere as a particulate embolic agent: an experimental study.

Authors:  Y Kai; J Hamada; M Morioka; T Todaka; S Hasegawa; Y Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

2.  Clinical evaluation of cellulose porous beads for the therapeutic embolization of meningiomas.

Authors:  Y Kai; J-I Hamada; M Morioka; S Yano; H Nakamura; K Makino; T Mizuno; H Takeshima; J-I Kuratsu
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

3.  Appropriate interval between embolization and surgery in patients with meningioma.

Authors:  Yutaka Kai; Jun-ichiro Hamada; Motohiro Morioka; Shigetoshi Yano; Tatemi Todaka; Yukitaka Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

4.  Preoperative cellulose porous beads for therapeutic embolization of meningioma: provocation test and technical considerations.

Authors:  Yutaka Kai; Jun-Ichiro Hamada; Motohiro Morioka; Shigetoshi Yano; Hideo Nakamura; Keishi Makino; Takamasa Mizuno; Hideo Takeshima; Jun-Ichi Kuratsu
Journal:  Neuroradiology       Date:  2007-02-22       Impact factor: 2.804

5.  Renal artery embolization using a new liquid embolic material obtained by partial hydrolysis of polyvinyl acetate (Embol): initial experience in six patients.

Authors:  S I Park; D Y Lee; J Y Won; S Park
Journal:  Korean J Radiol       Date:  2000 Jul-Sep       Impact factor: 3.500

6.  Pre- and post-treatment MR imaging and single photon emission CT in patients with dural arteriovenous fistulas and retrograde leptomeningeal venous drainage.

Authors:  Yutaka Kai; Jun-ichiro Hamada; Motohiro Morioka; Tatemi Todaka; Takamasa Mizuno; Yukitaka Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

7.  A Case of Periodontal Necrosis following Embolization of Maxillary Artery for Epistaxis.

Authors:  Kohei Nishimoto; Ryosei Minoda; Ryoji Yoshida; Toshinori Hirai; Eiji Yumoto
Journal:  Case Rep Otolaryngol       Date:  2016-11-21

8.  Successful transarterial embolization with cellulose porous beads for occipital haemangioma in an infant with Kasabach-Merritt syndrome.

Authors:  Zaw Aung Khant; Toshinori Hirai; Osamu Ikeda; Eiji Furukoji; Yoshihito Kadota; Minako Azuma; Norihiro Shinkawa; Keiji Kitatani; Yoichi Mizutani; Kimihiko Endo; Yasuyuki Yamashita
Journal:  BJR Case Rep       Date:  2017-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.